| RYWAX | WCMNX | RYWAX / WCMNX | |
| Total Expense Ratio | 1.56 | 1.24 | 126% |
| Annual Report Gross Expense Ratio | 1.61 | 2.04 | 79% |
| Fund Existence | 23 years | 7 years | - |
| Gain YTD | 25.218 | 11.144 | 226% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.97M | 51.9M | 15% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 29.13 | 16.65 | 175% |
| Returns for 3 years | 46.08 | 31.41 | 147% |
| Returns for 5 years | -22.93 | 1.76 | -1,305% |
| Returns for 10 years | 18.91 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BHSRX | 63.40 | 0.82 | +1.31% |
| BlackRock Health Sciences Opps R | |||
| GMWEX | 13.76 | 0.13 | +0.97% |
| GuideMark® World ex-US Service | |||
| TASMX | 32.96 | 0.23 | +0.70% |
| Transamerica Small/Mid Cap Value R6 | |||
| MDFOX | 6.82 | 0.03 | +0.44% |
| BlackRock Large Cap Focus Growth Inv A | |||
| CUSRX | 14.95 | 0.03 | +0.20% |
| Cullen Small Cap Value Retail | |||